Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer
Future Medicinal Chemistry · 2023
DOI: 10.4155/fmc-2023-0105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2023. Verfasst von Sharba Tasneem und 10 weiteren Autor:innen. Beteiligte Einrichtung: Drug Design & Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delh…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Design & Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India.
- Department of Elementology & Toxicology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
- Department of Biochemistry, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
- Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India.
ORCID-Profile: M Mumtaz Alam, Suhel Parvez, Farah Khan, Mymoona Akhter, Shaista Amin, Mohammad Ahmed Khan, Mohammad Shaquiquzzaman
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Tasneem, S., Alam, M. M., Parvez, S., Pinky, Khan, F., Garg, M., Amir, M., Akhter, M., Amin, S., Khan, M. A., & Shaquiquzzaman, M. (2023). Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0105
Vancouver
Tasneem S, Alam MM, Parvez S, Pinky, Khan F, Garg M, et al. Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer. Future Medicinal Chemistry. 2023. doi:10.4155/fmc-2023-0105
BibTeX
@article{Tasneem2023,
author = {Tasneem, Sharba and Alam, M Mumtaz and Parvez, Suhel and Pinky and Khan, Farah and Garg, Manika and Amir, Mohd and Akhter, Mymoona and Amin, Shaista and Khan, Mohammad Ahmed and Shaquiquzzaman, Mohammad},
title = {Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer},
journal = {Future Medicinal Chemistry},
year = {2023},
doi = {10.4155/fmc-2023-0105}
}
EUVIMED